FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310056589> ?p ?o ?g. }

• W4310056589 endingPage "5849" @default.
• W4310056589 startingPage "5849" @default.
• W4310056589 abstract "Diffuse large B-cell lymphoma (DLBCL) with MYC alteration is classified as high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (double/triple-hit lymphoma; DHL/THL), DLBCL with MYC rearrangement (single-hit lymphoma; SHL) and DLBCL with MYC-cluster amplification (MCAD). To elucidate the genetic features of DHL/THL, SHL, and MCAD, 23 lymphoma cases from Tokai University Hospital were analyzed. The series included 10 cases of DHL/THL, 10 cases of SHL and 3 cases of MCAD. The analysis used whole-genome copy number microarray analysis (OncoScan) and a custom-made next-generation sequencing (NGS) panel of 115 genes associated with aggressive B-cell lymphomas. The copy number alteration (CNA) profiles were similar between DHL/THL and SHL. MCAD had fewer CNAs than those of DHL/THL and SHL, except for +8q24. The NGS profile characterized DHL/THL with a higher mutation burden than SHL (17 vs. 10, p = 0.010), and the most relevant genes for DHL/THL were BCL2 and SOCS1, and for SHL was DTX1. MCAD was characterized by mutations of DDX3X, TCF3, HLA-A, and TP53, whereas MYC was unmutated. In conclusion, DHL/THL, SHL, and MCAD have different profiles." @default.
• W4310056589 created "2022-11-30" @default.
• W4310056589 creator A5010517161 @default.
• W4310056589 creator A5029161067 @default.
• W4310056589 creator A5036593794 @default.
• W4310056589 creator A5040539086 @default.
• W4310056589 creator A5041538504 @default.
• W4310056589 creator A5043642745 @default.
• W4310056589 creator A5046011913 @default.
• W4310056589 creator A5069692032 @default.
• W4310056589 creator A5074064898 @default.
• W4310056589 creator A5078999372 @default.
• W4310056589 creator A5084180858 @default.
• W4310056589 date "2022-11-27" @default.
• W4310056589 modified "2023-10-07" @default.
• W4310056589 title "Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification" @default.
• W4310056589 cites W2004916962 @default.
• W4310056589 cites W2034060278 @default.
• W4310056589 cites W2057631038 @default.
• W4310056589 cites W2075704822 @default.
• W4310056589 cites W2118028844 @default.
• W4310056589 cites W2119994239 @default.
• W4310056589 cites W2153944703 @default.
• W4310056589 cites W2159862107 @default.
• W4310056589 cites W2160848167 @default.
• W4310056589 cites W2166170465 @default.
• W4310056589 cites W2167179022 @default.
• W4310056589 cites W2214176334 @default.
• W4310056589 cites W2216659987 @default.
• W4310056589 cites W2406451651 @default.
• W4310056589 cites W2536954905 @default.
• W4310056589 cites W2598696175 @default.
• W4310056589 cites W2743064314 @default.
• W4310056589 cites W2746315886 @default.
• W4310056589 cites W2762091260 @default.
• W4310056589 cites W2762450632 @default.
• W4310056589 cites W2782690679 @default.
• W4310056589 cites W2785831779 @default.
• W4310056589 cites W2788380546 @default.
• W4310056589 cites W2790196207 @default.
• W4310056589 cites W2791077348 @default.
• W4310056589 cites W2797584152 @default.
• W4310056589 cites W2799566498 @default.
• W4310056589 cites W2801763724 @default.
• W4310056589 cites W2807906520 @default.
• W4310056589 cites W2890023109 @default.
• W4310056589 cites W2896150319 @default.
• W4310056589 cites W2902093381 @default.
• W4310056589 cites W2902375153 @default.
• W4310056589 cites W2903278833 @default.
• W4310056589 cites W2910996719 @default.
• W4310056589 cites W2922610698 @default.
• W4310056589 cites W2972566401 @default.
• W4310056589 cites W2987067520 @default.
• W4310056589 cites W2994968765 @default.
• W4310056589 cites W2999605898 @default.
• W4310056589 cites W3016044607 @default.
• W4310056589 cites W3097004036 @default.
• W4310056589 cites W3147827259 @default.
• W4310056589 cites W3154170002 @default.
• W4310056589 cites W3156014087 @default.
• W4310056589 cites W3186998997 @default.
• W4310056589 cites W3193291959 @default.
• W4310056589 cites W3209542195 @default.
• W4310056589 cites W3210165916 @default.
• W4310056589 cites W3213260823 @default.
• W4310056589 cites W4200450486 @default.
• W4310056589 cites W4205092749 @default.
• W4310056589 cites W4206930899 @default.
• W4310056589 cites W4281625438 @default.
• W4310056589 cites W4283381496 @default.
• W4310056589 cites W4307943844 @default.
• W4310056589 cites W977201031 @default.
• W4310056589 cites W3012996635 @default.
• W4310056589 doi "https://doi.org/10.3390/cancers14235849" @default.
• W4310056589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36497332" @default.
• W4310056589 hasPublicationYear "2022" @default.
• W4310056589 type Work @default.
• W4310056589 citedByCount "2" @default.
• W4310056589 countsByYear W43100565892023 @default.
• W4310056589 crossrefType "journal-article" @default.
• W4310056589 hasAuthorship W4310056589A5010517161 @default.
• W4310056589 hasAuthorship W4310056589A5029161067 @default.
• W4310056589 hasAuthorship W4310056589A5036593794 @default.
• W4310056589 hasAuthorship W4310056589A5040539086 @default.
• W4310056589 hasAuthorship W4310056589A5041538504 @default.
• W4310056589 hasAuthorship W4310056589A5043642745 @default.
• W4310056589 hasAuthorship W4310056589A5046011913 @default.
• W4310056589 hasAuthorship W4310056589A5069692032 @default.
• W4310056589 hasAuthorship W4310056589A5074064898 @default.
• W4310056589 hasAuthorship W4310056589A5078999372 @default.
• W4310056589 hasAuthorship W4310056589A5084180858 @default.
• W4310056589 hasBestOaLocation W43100565891 @default.
• W4310056589 hasConcept C104317684 @default.
• W4310056589 hasConcept C159654299 @default.
• W4310056589 hasConcept C203014093 @default.
• W4310056589 hasConcept C2777537477 @default.
• W4310056589 hasConcept C2778453870 @default.

• next